詳細検索

詳細検索

お問い合わせ

Tsumura and Co (4540:TYO) - Strategic SWOT and Financial Analysis - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Financial and Operational KPIs, and Recent Trends

Tsumura and Co (4540:TYO) - Strategic SWOT and Financial Analysis - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Financial and Operational KPIs, and Recent Trends


Report Summary Tsumura & Co Strategic SWOT Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Rece... もっと見る

 

 

出版社
Quaintel Research
クアインテルリサーチ
出版年月
2026年6月10日
電子版価格
納期
3-4営業日程度
ページ数
103
言語
英語

日本語のページはAI翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

Summary

Report Summary

Tsumura & Co Strategic SWOT Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of Tsumura & Co's business operations. It provides a detailed analysis of the company's financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.

The report begins with in-depth information about Tsumura & Co including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.

Next, the report assesses Tsumura & Co's strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of Tsumura & Co's overall strategic standing and supports informed decision-making and strategic planning.

The report also covers Tsumura & Co's financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares Tsumura & Co's financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors' operations.

Finally, the report includes recent news and deal activities undertaken by Tsumura & Co enhancing awareness of the company's business trends, growth perspectives, and more.

Key Highlights

Tsumura & Co., incorporated on 1893 by Jusha Tsumura in Tokyo, Japan. Headquartered at 2-17-11 Akasaka, Minato-ku, Tokyo, Japan, the company has grown into a leader in the pharmaceutical sector, specializing in Kampo medicines traditional Japanese herbal formulations derived from natural crude drugs. Operating primarily in healthcare and drug manufacturing, Tsumura focuses on producing Kampo extract intermediates, granular formulations, prescription drugs, over-the-counter medicines, and health foods targeting conditions like fatigue, gastrointestinal issues, stress, and women's health. Its commitment to blending ancient herbal practices with modern scientific research drives innovation, with significant R&D investment supporting over 140 Kampo products. Tsumura maintains a strong presence in Asia, particularly Japan, China, and South Korea, where it exports Kampo medicines and operates subsidiaries like Tsumura China Inc. and Ping An Tsumura Inc. for procurement and research. Overseas sales, accounting for about 15% of revenue, extend to North America and Europe, reflecting growing global demand for natural healthcare solutions. With 4,272 consolidated employees as of March 2025 and listing on the Tokyo Stock Exchange (ticker: 4540), Tsumura continues advancing wellness through quality and sustainability.

Tsumura & Co in the News:-

2025-06-18 - Notice regarding the conclusion of an agreement for Tsumura China Inc. to acquire an interest in Shanghai Hongqiao Traditional Chinese Drug Pieces Co., Ltd
2025-05-12 - Notice regarding the continuation of Trust-type Stock Delivery System for Employees
2025-02-06 - Tsumura Announces Conclusion of Letter of Intent between Ping An Tsumura Inc. and Shanghai Hongqiao Pharmaceutical Co., Ltd.


Scope

• Tactical Analysis:- Various strategic frameworks to gain insights into a Tsumura & Co's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
• Business Strategy:- Contributes to shaping the Tsumura & Co's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
• Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company's future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
• Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
• Competitive Landscape:- An identification of the Tsumura & Co's main competitors, providing insights into the competitive landscape it operates in.

Reasons to Buy

• Comprehensive Understanding of the Tsumura & Co's internal and external factors through SWOT analysis, Financial Analysis, and Competitors Benchmarking.
• Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
• Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
• Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
• Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
• Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.

Additionally, available deep-dive analysis on the company Tsumura & Co:

• Tsumura & Co PESTLE Analysis
• Tsumura & Co Value Chain Analysis
• Tsumura & Co Porter's Five Forces Analysis
• Tsumura & Co VRIO Analysis
• Tsumura & Co BCG Analysis
• Tsumura & Co Segmentation, Targeting and Positioning (STP) Analysis
• Tsumura & Co Ansoff Matrix Analysis

ページTOPに戻る


Table of Contents

Table of Contents 2
Tables 5
Charts 6
Tsumura & Co - Key Company Facts 7
Tsumura & Co - Company Description 8
Tsumura & Co - Top Executives 9
Tsumura & Co - Head Office & Locations 10
Head Office - Country 10
Tsumura & Co - Products and Services 11
Products 11
Services 12
Tsumura & Co - Corporate Strategy 13
Tsumura & Co - Business Description 17
Sales of Pharmaceutical Products 18
Tsumura & Co - ESG Spotlight 20
Environment 20
Social 21
Corporate Governance 21
Tsumura & Co - SWOT Analysis 23
Overview 23
Strengths 25
Weaknesses 27
Opportunities 29
Threats 31
Tsumura & Co - Financial Deep Dive 33
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 33
Profit and Loss Statement 35
Summary of Profit and Loss Statement 35
Balance Sheet 39
Summary of Balance Sheet 39
Cash Flow Statement 43
Summary of Cash Flow Statement 43
Key Financial Ratio Analysis 47
Tsumura & Co - Ratio Charts 49
Activity Ratio Charts 49
Growth Ratios Charts 50
Leverage Ratio Charts 54
Liquidity Ratio Charts 56
Profitability Ratio Charts 58
Competing Players 60
Snapshot of Competing Players 61
Hisamitsu Pharmaceutical Co Inc 61
Key Company Facts 61
Company Description 61
Key Financials 62
Share Price Trend - Jun-2025 to May-2026 (Average Share Closing Price) 62
Key Financial Ratio Analysis 67
Kobayashi Pharmaceutical Co Ltd 69
Key Company Facts 69
Company Description 69
Key Financials 70
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 70
Key Financial Ratio Analysis 75
Yakult Honsha Co., Ltd 77
Key Company Facts 77
Company Description 77
Key Financials 78
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 78
Key Financial Ratio Analysis 83
Kracie, Ltd 85
Key Company Facts 85
Company Description 85
Tsumura & Co - In the News 86
18-Jun-2025 - Notice regarding the conclusion of an agreement for Tsumura China Inc. to acquire an interest in Shanghai Hongqiao Traditional Chinese Drug Pieces Co., Ltd 86
Appendix 87
Definitions 87
SWOT Analysis 87
PESTLE Analysis 87
Value Chain Analysis 87
ESG Spotlight 87
Financial Deep Dive 87
Financial Ratios 88
Activity Ratios 88
Growth Ratios 90
Leverage Ratios 93
Liquidity Ratios 95
Market Ratios 97
Profitability Ratios 99
Research Methodology 101
Disclaimer 102
Contact Us 102

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療/ヘルスケア)の最新刊レポート

Quaintel Research社の 医薬品・医療分野 での最新刊レポート

本レポートと同じKEY WORD(corporate)の最新刊レポート


よくあるご質問


Quaintel Research社はどのような調査会社ですか?


Quaintel Researchはインドを拠点をとする調査会社です。 様々な企業の分析を行っており、企業の競合分析に役立つ資料をご提供します。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2026/08/17 10:26

160.11 円

185.73 円

219.67 円

ページTOPに戻る